TMC Life Sciences Berhad (KLSE:TMCLIFE)

TMC Life Sciences Berhad Balance Sheet

Financials in millions MYR. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	111.64	109.56	188.57	166.54	141.14
Short-Term Investments	3.42	2.07	2.56	2.15	2
Cash & Short-Term Investments	115.06	111.64	191.13	168.69	143.14
Cash Growth	3.07%	-41.59%	13.30%	17.85%	1.40%
Accounts Receivable	42.16	42.67	31.13	38.41	24.29
Other Receivables	16.86	28.91	25.57	29.15	24.18
Receivables	59.01	71.59	56.7	67.56	48.47
Inventory	20.55	15.91	11.62	13.37	10.88
Prepaid Expenses	2.67	3.35	3.09	2.17	2.06
Total Current Assets	197.3	202.48	262.54	251.8	204.55
Property, Plant & Equipment	715.22	725.78	718.27	715.15	728.45
Goodwill	193.05	193.05	193.05	193.05	193.05
Other Intangible Assets	2.81	8.15	13.45	12.55	1.68
Long-Term Deferred Tax Assets	0.69	0.7	0.32	2.09	2.91
Other Long-Term Assets	5.98	2.04	2.1	2.16	2.22
Total Assets	1,115	1,132	1,190	1,177	1,133

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	24.75	26.88	18.45	19.9	25.57
Accrued Expenses	16.63	13.28	20.19	22.06	15.74
Current Portion of Long-Term Debt	45.11	37.61	22.6	15.1	7.6
Current Portion of Leases	1.97	2.34	2.7	2.59	2.44
Current Income Taxes Payable	1.12	0.56	0.38	0.05	0.01
Current Unearned Revenue	0.6	0.52	0.53	-	-
Other Current Liabilities	26.76	29.13	33.78	38.87	38.93
Total Current Liabilities	116.93	110.31	98.62	98.57	90.28
Long-Term Debt	96.54	141.43	178.83	198.38	196.17
Long-Term Leases	1.6	1.6	1.1	2.99	4.24
Long-Term Unearned Revenue	0.38	0.36	0.26	-	-
Long-Term Deferred Tax Liabilities	31.74	24.72	22.66	14.41	14.39
Other Long-Term Liabilities	0.67	0.74	0.22	0.49	0.38
Total Liabilities	247.86	279.15	301.69	314.84	305.46

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	625.99	625.99	625.99	625.99	625.99
Retained Earnings	241.19	227.06	260.73	234.56	199.69
Comprehensive Income & Other	-	-	1.32	1.42	1.71
Shareholders' Equity	867.18	853.04	888.03	861.96	827.39
Total Liabilities & Equity	1,115	1,132	1,190	1,177	1,133

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	145.22	182.97	205.23	219.06	210.44
Net Cash (Debt)	-30.15	-71.33	-14.1	-50.37	-67.3
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.02	-0.04	-0.01	-0.03	-0.04
Filing Date Shares Outstanding	1,742	1,742	1,742	1,742	1,742
Total Common Shares Outstanding	1,742	1,742	1,742	1,742	1,742
Working Capital	80.36	92.17	163.92	153.23	114.26
Book Value Per Share	0.50	0.49	0.51	0.49	0.47
Tangible Book Value	671.33	651.85	681.54	656.36	632.66
Tangible Book Value Per Share	0.39	0.37	0.39	0.38	0.36
Land	180	180	180	180	180
Buildings	357.94	357.94	357.74	355.3	353.21
Machinery	212.38	200.18	178.87	172.47	156.23
Construction In Progress	105.05	101.91	109.3	97.32	108.69

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error